MedPath

Ultrasound Guided Serratus Anterior Plane Block Versus Thoracic Erector Spinae Plane Block for Post Operative Analgesia in Pediatrics Undergoing Thoracotomy

Not Applicable
Completed
Conditions
Ultrasound
Serratus Anterior Plane Block
Thoracic Erector Spinae Plane Block
Post Operative Analgesia
Pediatrics
Thoracotomy
Interventions
Drug: Control group
Drug: Serratus Anterior Plane Block (SAPB) group
Drug: Erector Spinae Plane Block (ESPB) group
Registration Number
NCT06862518
Lead Sponsor
Tanta University
Brief Summary

This study is designed to compare the post operative analgesic effect of serratus anterior plane block versus thoracic erector spinae plane block in pediatrics undergoing thoracotomy

Detailed Description

The incidence of diseases that requires thoracotomy is low in the pediatric age group. Thoracotomy is a severe burden on children and is widely known to cause severe acute pain. This pain can be very distressing for both children and their parents. If not treated properly, it may acutely cause retention of secretion, atelectasis, ventilation-perfusion disorder and hypoxemia, together with a change in lung mechanics.

The serratus anterior plane block (SAPB) has also recently become more popular options for post-thoracotomy analgesia. SAPB involves local anesthetic injection in a plane superficial or deep to the serratus anterior muscle; in both these locations, it blocks the lateral cutaneous branches of intercostal nerves.

The erector spinae plane block (ESPB) is an ultrasound-guided deep plane interfascial block defined by Forero in 2016. It has been shown to provide thoracic and abdominal analgesia. When injected at the T5 transverse process level, the local anesthetic spreads anteriorly through the thoracolumbar fascia and reaches the ventral and dorsal rami of the spinal nerves and posteriorly to the gray and white rami communicantes of the sympathetic chain, providing a C7 to T8 sensitive block. Although it was first described as a chronic pain block, there are increasingly reports about its use in postoperative acute pain.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • Patient aged between 2 and 7 years.
  • Patient posted for the right or left thoracotomy under general anesthesia.
Exclusion Criteria
  • Parents who refuse regional anesthesia.
  • Children who had any coagulation abnormality.
  • Deformity of the thoracolumbar spine.
  • Infection at the site of injection.
  • History of allergy to the local anesthetics.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupControl groupPatients will receive general anesthesia alone
Serratus Anterior Plane Block (SAPB) groupSerratus Anterior Plane Block (SAPB) groupPatients will receive general anesthesia (GA) with ultrasound guided serratus anterior plane block 0.5 ml/kg 0.25% bupivacaine.
Erector Spinae Plane Block (ESPB) groupErector Spinae Plane Block (ESPB) groupPatients will receive general anesthesia (GA) with ultrasound guided erector spinae plane block 0.5 ml/kg 0.25% bupivacaine.
Primary Outcome Measures
NameTimeMethod
Total rescue analgesia consumption24 hours postoperatively

Rescue analgesia is planned based on the patients' face, leg, activity, cry, consolability score (FLACC) scores. Morphine 0.05 mg/kg IV was given as rescue analgesia in the case of FLACC scores above 3.The analgesic requirements in the first 24 h postoperatively were recorded.

Secondary Outcome Measures
NameTimeMethod
Time to 1st rescue analgesic requirement24 hours postoperatively

Time to 1st request for the rescue of analgesia (time from the end of surgery till first dose of morphine administrated) was recorded.

Degree of pain24 hours postoperatively

Pain was assessed after surgery over 24 hours using face, leg, activity, cry, consolability score (FLACC) score at following times: 0 (baseline), 1, 3, 6, 8, 12, and 24 h postoperative. FLACC score is used for pain assessment. (Face, legs, activity, cry and Consolability) is a measurement used to assess pain in children between age of 2 to 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0 to 10 with 0 representing no pain, 10 representing the maximum and we start to give rescue analgesia at score 4.

Trial Locations

Locations (1)

Tanta University

🇪🇬

Tanta, El-Gharbia, Egypt

© Copyright 2025. All Rights Reserved by MedPath